HOME >> BIOLOGY >> NEWS
Common Childhood Virus Poses Threat To Adults, Research Shows

and less than 40 years old.

While 135 patients tested positive for RSV antibodies, only the 57 whose level of antibodies quadrupled over the course of a month were considered true cases of RSV for the study. In some patients, researchers noticed the effects of bacterial infection, which indicates they might have acquired a bacterial pneumonia along with or after RSV infection.

“Doctors used to think that adults who acquire RSV may get cold symptoms, not pneumonia,” said Murry. “But in fact, a third of the 57 RSV patients in this study had changes in their lung X-rays which were probably RSV-related.”

The RSV virus attacks the epithelial cells that line the airways in the lungs. It spreads as people cough up infected epithelial cells, so hand washing is the best way to limit the spread of RSV.

RSV is the leading cause of severe lower respiratory tract infection in infants and young children. According to Murry, nearly every child in the United States acquires RSV before the age of two, as their immune systems are developing. Adults most vulnerable to infection are those who have undergone chemotherapy or organ transplants, as well as those with HIV.

If a patient has a severe enough case of RSV to need the help of a breathing machine, doctors can treat the infection with Ribovarin, an anti-viral drug. Doctors dissolve the drug in saline, and patients inhale it through a mist.

Symptoms of RSV persist even after the patient is discharged from the hospital.

“When people go home, it may be a while before they feel completely better, because the damage to their airways will take at least 8 weeks to heal,” said Murry. “So they’ll remain kind of wheezy and a little short of breath for that time. Most people can go back to work as soon as they go home from the hospital.”

Murry said a normal person couldn’t easily tell whether they have RSV or just a nasty cold. One clue i
'"/>

Contact: Andrew R. Murry
Murry.1@osu.edu
614-293-8745
Ohio State University
29-Aug-1997


Page: 1 2 3

Related biology news :

1. Common cold virus can cause polio in mice when injected into muscles
2. Common call for action on European Research Council (ERC)
3. Common therapy for HIV associated with cervical abnormality regression
4. Common chemicals morphing into potential toxins in Arctic
5. Common worm provides insights into salmonella virulence
6. Common virus may contribute to uncommon bone disease in children
7. Common airborne substance makes asthmatics more sensitive to house dust mites: study
8. Common genetic damages in non-dividing cells lead to the creation of mutant proteins
9. Common nutrients fed to pregnant mice altered their offsprings coat color
10. Common treatment for depression is safe and effective for Alzheimers patients
11. Common gene variant increases risk of atherosclerosis

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/6/2016)... 2016 Securus Technologies, a leading provider ... public safety, investigation, corrections and monitoring, and the ... five (5) year funding commitment by Securus to ... rehabilitation and reentry support to more inmates and ... 2004, the Prison Entrepreneurship Program (PEP) is an ...
(Date:12/2/2016)... , December 1, 2016 ... (Fingerprint, Voice), Future Technology (Iris Recognition System), Vehicle ... - Global Forecast to 2021", published by MarketsandMarkets, ... Million in 2016, and is projected to grow ... CAGR of 14.06%.      (Logo: http://photos.prnewswire.com/prnh/20160303/792302) ...
(Date:11/30/2016)... WARSAW, Poland , Nov. 30, 2016 Not many of us realize ... crucial aspects of recovery so we need to do it well. Inadequate sleep levels ... problems, high blood pressure, stroke, diabetes, and even cancer. Maybe now is ... Christmas present that could help them to manage their sleep quality? ... ...
Breaking Biology News(10 mins):
(Date:12/7/2016)... report "Acrylic Processing Aid Market by Polymer Type (PVC), Fabrication Process (Extrusion, Injection Molding), End-Use ... published by MarketsandMarkets, the global market size was USD 645.4 Million in 2016, ... CAGR of 6.2% between 2016 and 2026. Continue ... ... , , ...
(Date:12/7/2016)... 2016  Genprex, Inc. a biopharmaceutical company focused ... today announced that it has retained ICR Healthcare, ... communications and advisory firm, to develop and implement ... combine investor relations, public relations and digital communications ... of Genprex and its lead candidate Oncoprex, which ...
(Date:12/7/2016)... and ANN ARBOR, Mich. , ... biopharmaceutical company developing breakthrough immune modulatory medicines, announced today ... the Company,s lead therapeutic candidate, LYC-30937- E nteric ... a debilitating skin disease that is estimated to affect ... United States , with approximately 1.5 - 3 ...
(Date:12/7/2016)... CA (PRWEB) , ... December 07, 2016 , ... ... wastewater treatment and resource recovery solutions for industrial facilities, today announced that one ... be the first to use Cambrian’s novel water-energy purchase agreement (WEPA). Under the ...
Breaking Biology Technology:
Cached News: